Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -10.2120.685.2614.2023.15

What is the latest EBIT Growth ratio of LINCOLN PHARMACEUTICALS ?

The latest EBIT Growth ratio of LINCOLN PHARMACEUTICALS is -10.21 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-10.21
Mar202420.68
Mar20235.26
Mar202214.20
Mar202123.15

How is EBIT Growth of LINCOLN PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 -10.21
Negative
Mar2024 20.68
293.16
Mar2023 5.26
-62.96
Mar2022 14.2
-38.66
Mar2021 23.15 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EBIT Growth ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,201.5 Cr -2.9% -7.2% 11.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,825.0 Cr -1.6% 5.7% 7.7% Stock Analytics
DIVIS LABORATORIES ₹161,535.0 Cr -4.2% -1.4% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,733.0 Cr -2.8% 5.7% 39.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,094.0 Cr -3.2% 1.2% 14.2% Stock Analytics
CIPLA ₹103,513.0 Cr -3.6% -3.7% -10.2% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-2.9%

-7.2%

11.9%

SENSEX

-2.7%

-9.1%

2.6%


You may also like the below Video Courses